Further explanations here about the test and the FDA's response. It also lists the two types of tests that are currently on the market.
http://www.pharmastrategyblog.com/2010/03/chemgenix-will-need-a-validated-t315i-mutation-test-for-omacetaxine-in-cml.html
"This isn't really surprising: if you are claiming to target a particular marker or target, then you need a validated companion diagnostic test to be commercially available once the drug is approved. I think what the FDA is saying to ChemGenex is that they need to do a small study comparing and validating the data between commercial assays and the ones used more commonly in hospital Path labs for research purposes and clinical trials. It's not a big deal, but it does need to be done."
- Forums
- ASX - By Stock
- CXS
- t315i mutation testing
t315i mutation testing , page-11
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online